GREENFIELD, Ind., May 5, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the sale of certain future tiered royalties and commercial milestones associated with XDEMVY® (lotilaner ophthalmic solution) 0.25%, for the human health application of lotilaner,...
Hence then, the article about elanco sells royalty and milestone rights for lotilaner in human health to blackstone accelerates debt paydown was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown )
Also on site :
- Several Denver-area gas stations pumped contaminated fuel this week, King Soopers warns
- Man police shot in Brooklyn hospital was former NYPD officer, police said
- Parker Waichman LLP Files Lawsuit on behalf of Chicago Resident in the Paragard MDL Alleging Injuries Caused by Breakage of the Copper IUD